Safety and Efficacy of Bivalirudin in Diabetic Acute Coronary Syndrome (ACS) Patients Undergoing Percutaneous Coronary Intervention (PCI). European Journal of Medical and Health Sciences, [S. l.], v. 3, n. 2, p. 93–97, 2021. DOI: 10.24018/ejmed.2021.3.2.768. Disponível em: https://www.ej-med.org/index.php/ejmed/article/view/768. Acesso em: 19 oct. 2025.